‘ANAEMIA IN PREGNANCY-ASSOCIATED ACUTE KIDNEY INJURY (PRAKI) PATIENTS: A SILENT MARKER OF SEVERITY AND SURVIVAL’

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 


 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/d00d9e40343346771647763cbb34a6ff.pdf
‘ANAEMIA IN PREGNANCY-ASSOCIATED ACUTE KIDNEY INJURY (PRAKI) PATIENTS: A SILENT MARKER OF SEVERITY AND SURVIVAL’

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Dr. Medhavi
Gautam
Dr. Medhavi Gautam gautam.medhavi@gmail.com King George's Medical University , Lucknow Medicine Lucknow India *
Dr. Armin Ahmed drarminahmed@gmail.com King George's Medical University , Lucknow Critical Care Medicine Lucknow India -
Dr. Haris Nadeem Nadeemharis13@gmail.com King George's Medical University , Lucknow Emergency Medicine Lucknow India -
-
-
-
-
-
-
-
-
-
-
-
-

Anaemia is a major global health burden in obstetric patients and significantly contributes to increased feto-maternal morbidity and mortality, especially in critically ill cases with complications like haemorrhage, sepsis, and hypertensive disorders. It significantly worsens outcomes and often coexists with acute kidney injury, highlighting vital organ crosstalk with renal dysfunction.

Aims and Objectives:
This study aimed to evaluate the causes and outcomes of anaemia among critically ill obstetric patients diagnosed with Pregnancy-Related Acute Kidney Injury (PRAKI) and to explore its relationship with renal dysfunction, dialysis requirement, and survival outcomes.

Materials and Methods:

The current data have been derived from a larger retrospective, non-interventional, single-centre study that included 91 critically ill obstetric patients, conducted to evaluate the epidemiology of anaemia. The study was conducted in critically ill adult obstetric patients (aged 18 years or older) admitted to the hospital's intensive care unit between December 2023 and May 2025.  Those patients with concurrent diagnoses of anaemia and acute kidney injury were included for evaluation.

A total of 51 critically ill patients with pregnancy-related acute kidney injury (PRAKI) and anaemia were evaluated. The mean age was 27.7 ± 5.3 years. None of the patients had pre-existing comorbidities except two—one with chronic heart failure and the other with chronic kidney disease. Regarding antenatal care, 31 patients (60.78%) were booked, while 20 (39.21%) were unbooked. In terms of obstetric profile, 17 patients (33.33%) were primigravida and 34 (66.67%) were multigravida. Among these patients, 31(60.07%) underwent emergency lower segment caesarean section (LSCS), 2 (3.90%) had elective LSCS, and 16 (31.37%) delivered vaginally. A total of 41 patients (80.39%) delivered preterm, i.e., before 37 weeks of gestation.

There were 35 (68.60%) survivors and 16 (31.30%) non-survivors. The median SOFA score at admission was 10, and the median APACHE-2 score was 21. All patients except 3 required mechanical ventilator support during their ICU stay. The median duration of mechanical ventilation was 4 days. Thirty-six patients (76.50%) required vasopressor support either at admission or during their hospital stay. {Table 1}

Table 1:Basic Demographic profile

Variable

Number of patients (%)

Mean Age (years)

27.7 ± 5.3 years

Pre-existing Comorbidities

2 patients (1 CHF, 1 CKD)

Booked Cases (Antenatal Care)

31 (60.78%)

Unbooked Cases

20 (39.21%)

Primigravida

17 (33.33%)

Multigravida

34 (66.67%)

Emergency LSCS

31 (60.07%)

Elective LSCS

2 (3.90%)

Vaginal Delivery

16 (31.37%)

Preterm Deliveries (<37 weeks)

41 (80.39%)

Survivors

35 (68.60%)

Non-survivors

16 (31.30%)

Median SOFA Score at Admission

10

Median APACHE II Score

21

Mechanical Ventilation Required

48 (94.1%)

Median Duration of Mechanical Ventilation (days)

4

Vasopressor Support Required

36 (76.50%)

Mean Serum Creatinine at Admission (mg/dL)

3.3

Dialysis Support Required

23 (45.09%)

The most common diagnoses were sepsis (39.21%), pre-eclampsia/eclampsia (35.29%), postpartum haemorrhage (9.80%), HELLP syndrome (7.84%), and acute fatty liver/associated liver injury (7.84%), emphasising sepsis and hypertensive disorders as leading causes of PRAKI. The mean serum creatinine at admission was 3.3 mg/dL, confirming moderate-to-severe renal dysfunction. Among all patients, 23 (45.09%) required dialysis support. {Figure 1}

Figure 1: Distribution of Diagnosis among PRAKI patients 

Figure 1 : Main causes of PRAKI patients

The mean haemoglobin level at admission was 7.70 ± 2.09 g/dL, with a mean MCV of 85.33 ± 9.61 fL. At discharge (or death), the mean haemoglobin was 8.09 ± 6.50 g/dL, and the mean MCV was 84.15 ± 14.8 fL, indicating persistent moderate-to-severe anaemia. Peripheral smear evaluation at admission revealed normocytic normochromic anaemia in 32 patients (62.70%), microcytic hypochromic anaemia in 12 patients (23.50%), and a mixed anaemia pattern in 7 patients (13.70%). Features of microangiopathic haemolytic anaemia (MAHA) were observed in 8 patients. {Table 2,3}

Table 2 :Hematological parameters of PRAKI patients

Red Cell Morphology

Mean +/- SD

Mean Haemoglobin at Admission (g/dL)

7.70 ± 2.09

Mean MCV at Admission (fL)

85.33 ± 9.61

Mean Haemoglobin at Discharge/Death (g/dL)

8.09 ± 6.50

Mean MCV at Discharge/Death (fL)

84.15 ± 14.8

Table 3: General Blood picture of patients

General Blood Picture

Number of Patients (%)

Peripheral Smear - Normocytic Normochromic

32 (62.70%)

Peripheral Smear - Microcytic Hypochromic

12 (23.50%)

Peripheral Smear - Mixed Anaemia

7 (13.70%)

Features of MAHA Observed

8 (15.68%)

The mean haemoglobin at admission among survivors was 7.80 g/dL, compared to 7.54 g/dL among non-survivors. At discharge or death, survivors had Hb of 8.49 g/dL, while non-survivors had 6.7 g/dL. {Figure 2}. We compared mean haemoglobin (Hb) and mean corpuscular volume (MCV) between survivors and non-survivors using an independent two-sample t-test; while neither Hb nor MCV at admission differed significantly between groups (p>0.05), survivors had significantly higher Hb at discharge (8.50 ± 1.93 g/dL vs. 7.19 ± 1.36 g/dL, p≈0.008), whereas MCV differences at discharge were not statistically significant (p≈0.132).

Figure 2 : Survivors versus Non Survivors among PRAKI patients

Although differences were modest, lower haemoglobin levels were associated with a poorer prognosis. 

Our study shows that anaemia, sepsis and hypertensive disorders were the leading causes of PRAKI, with 31.3% patients as non-survivors. While admission Hb and MCV did not differ significantly, lower discharge haemoglobin levels were linked to poorer outcomes, underscoring their prognostic value and the need for early, aggressive anaemia management.

Kewords